PI4KIIIBETA INHIBITORS

The invention relates to compounds of formula (I) which are inhibitors of kinase activity, pharmaceutical formulations containing the compounds and their uses in treating and preventing viral infections and disorders caused or exacerbated by the viral infectionwherein R1, R2, R3, R4a, R4b, R4c, R5,...

Full description

Saved in:
Bibliographic Details
Main Authors BERTRAND, Sophie Marie, DOWN, Kenneth, BARTON, Nicholas Paul, GRAY, Matthew
Format Patent
LanguageEnglish
Published 28.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to compounds of formula (I) which are inhibitors of kinase activity, pharmaceutical formulations containing the compounds and their uses in treating and preventing viral infections and disorders caused or exacerbated by the viral infectionwherein R1, R2, R3, R4a, R4b, R4c, R5, W, X, Y and Z are defined herein.
AbstractList The invention relates to compounds of formula (I) which are inhibitors of kinase activity, pharmaceutical formulations containing the compounds and their uses in treating and preventing viral infections and disorders caused or exacerbated by the viral infectionwherein R1, R2, R3, R4a, R4b, R4c, R5, W, X, Y and Z are defined herein.
Author GRAY, Matthew
BARTON, Nicholas Paul
BERTRAND, Sophie Marie
DOWN, Kenneth
Author_xml – fullname: BERTRAND, Sophie Marie
– fullname: DOWN, Kenneth
– fullname: BARTON, Nicholas Paul
– fullname: GRAY, Matthew
BookMark eNrjYmDJy89L5WQQC_A08fb09HRyDXFU8PTz8HTyDPEPCuZhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfHB7oaGRgZGBgZmJqbGwY7GRCoDAESDIlM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID SG11202006453SA
GroupedDBID EVB
ID FETCH-epo_espacenet_SG11202006453SA3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:06:08 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_SG11202006453SA3
Notes Application Number: SG20201106453S
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200828&DB=EPODOC&CC=SG&NR=11202006453SA
ParticipantIDs epo_espacenet_SG11202006453SA
PublicationCentury 2000
PublicationDate 20200828
PublicationDateYYYYMMDD 2020-08-28
PublicationDate_xml – month: 08
  year: 2020
  text: 20200828
  day: 28
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
RelatedCompanies_xml – name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Score 3.2799158
Snippet The invention relates to compounds of formula (I) which are inhibitors of kinase activity, pharmaceutical formulations containing the compounds and their uses...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PI4KIIIBETA INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200828&DB=EPODOC&locale=&CC=SG&NR=11202006453SA
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV05T8MwFH4qBQEbFCquog5VtogSHyRDhJqrMahJ1ATUrSKOKzFQKhrE38e2Uo4FNttPej6kd9rvM8BAYHzjVM7CtFBFTWxVlWlXjm0SQYYLbtOSOqo4eZLQ-AHfzcisBS-bWhiNE_qhwRGlRHEp77XW16vvJFag31aur8pnOfR6GxVuYDTRsaUR2YzAc8MsDVLf8H03HxvJ1JVuhaJSTFA-2oJt5UkrqP3w0VOFKaufViU6gJ1MMlzWh9ASyw7s-ZvP1zqwO2nuvGWzEb_1EXQzhu8ZY15YjPosiZnHinSaH8MgCgs_NuUE868NzfPxr-WgLrRlrC9OoI84RyUnSAatT9K1Ec6wlMpIUOuaK0hhcgq9P1md_UM_h33VU0lRy76Adv32LnrSqtblpT6LT882dk0
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT8JAEJ4gGvGmKPGFciC9NWK3W9pDY-iLrtBHaDXciG2XxINIpMa_72xTfFz0ttlJZh_JPHfmW4A-V9WhURhLWSGFJqtKUch6Yegy5XSwzHUt0wzRnByEmv-g3s_pvAEv216YCif0owJHRInKUd7LSl-vv5NYTlVbubnJnnHq9c5LTUeqo2OlQmSTHMt048iJbMm2zWQshTMT3QpB1VRKktEO7A4FQK_wnh4t0Ziy_mlVvEPYi5HhqjyCBl-1oWVvP19rw35Qv3njsBa_zTF0YqZOGGOWm456LPSZxdJolpxA33NT25dxgcXXgRbJ-Nd2SAeaGOvzU-iRPCdZTgkGrU_o2nBjkKEy4ppymwtIYXoG3T9Znf9Dv4aWnwbTxZSFkws4EBSRIFX0S2iWb--8ixa2zK6qe_kEfx15Og
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PI4KIIIBETA+INHIBITORS&rft.inventor=BERTRAND%2C+Sophie+Marie&rft.inventor=DOWN%2C+Kenneth&rft.inventor=BARTON%2C+Nicholas+Paul&rft.inventor=GRAY%2C+Matthew&rft.date=2020-08-28&rft.externalDBID=A&rft.externalDocID=SG11202006453SA